T. Kanda, K. Ishii, H. Kawaguchi, K. Kitajima, and D. Takenaka, High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-weighted MR Images: Relationship with Increasing Cumulative Dose of a Gadolinium-based Contrast Material, Radiology, vol.270, issue.3, pp.834-841, 2014.

A. Radbruch, L. D. Weberling, P. J. Kieslich, O. Eidel, S. Burth et al., Gadolinium Retention in the Dentate Nucleus and Globus Pallidus Is Dependent on the Class of Contrast Agent, Radiology, vol.275, issue.3, pp.783-791, 2015.

V. M. Runge, Safety of the Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging, Focusing in Part on Their Accumulation in the Brain and Especially the Dentate Nucleus, Investigative Radiology, vol.51, issue.5, pp.273-279, 2016.

T. Kanda, Y. Nakai, H. Oba, K. Toyoda, K. Kitajima et al., Gadolinium deposition in the brain, Magnetic Resonance Imaging, vol.34, issue.10, pp.1346-1350, 2016.

R. J. Mcdonald, J. S. Mcdonald, D. F. Kallmes, M. E. Jentoft, D. L. Murray et al., Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging, Radiology, vol.275, issue.3, pp.772-782, 2015.

P. Robert, S. Lehericy, S. Grand, X. Violas, N. Fretellier et al., T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats, Investigative Radiology, vol.50, issue.8, pp.473-480, 2015.

A. Pa?asz and P. Czekaj, Toxicological and cytophysiological aspects of lanthanides action., Acta Biochimica Polonica, vol.47, issue.4, pp.1107-1114, 2000.

T. Grobner, Gadolinium ? a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?, Nephrology Dialysis Transplantation, vol.21, issue.4, pp.1104-1108, 2006.

J. M. Idée, N. Fretellier, C. Robic, and C. Corot, The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update, Critical Reviews in Toxicology, vol.44, issue.10, pp.895-913, 2014.

M. Port, J. M. Idée, C. Medina, C. Robic, M. Sabatou et al., Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review, BioMetals, vol.21, issue.4, pp.469-490, 2008.

T. Frenzel, P. Lengsfeld, H. Schirmer, J. Hütter, and H. Weinmann, Stability of Gadolinium-Based Magnetic Resonance Imaging Contrast Agents in Human Serum at 37°C, Investigative Radiology, vol.43, issue.12, pp.817-828, 2008.

N. Fretellier, J. M. Idée, A. Dencausse, O. Karroum, S. Guerret et al., Comparative In Vivo Dissociation of Gadolinium Chelates in Renally Impaired Rats, Investigative Radiology, vol.46, issue.5, pp.292-300, 2011.

T. Frenzel, C. Apte, G. Jost, L. Schöckel, J. Lohrke et al., Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents, Investigative Radiology, vol.52, issue.7, pp.396-404, 2017.

P. Robert, S. Fingerhut, C. Factor, V. Vives, J. Letien et al., One-year Retention of Gadolinium in the Brain: Comparison of Gadodiamide and Gadoterate Meglumine in a Rodent Model, Radiology, vol.288, issue.2, pp.424-433, 2018.

E. Gianolio, P. Bardini, F. Arena, R. Stefania, E. Di-gregorio et al., Gadolinium Retention in the Rat Brain: Assessment of the Amounts of Insoluble Gadolinium-containing Species and Intact Gadolinium Complexes after Repeated Administration of Gadolinium-based Contrast Agents, Radiology, vol.285, issue.3, pp.839-849, 2017.

G. Jost, T. Frenzel, J. Boyken, J. Lohrke, V. Nischwitz et al., Long-term Excretion of Gadolinium-based Contrast Agents: Linear versus Macrocyclic Agents in an Experimental Rat Model, Radiology, vol.290, issue.2, pp.340-348, 2019.

M. A. Sieber, P. Lengsfeld, T. Frenzel, S. Golfier, H. Schmitt-willich et al., Preclinical investigation to compare different gadolinium-based contrast agents regarding their propensity to release gadolinium in vivo and to trigger nephrogenic systemic fibrosis-like lesions, European Radiology, vol.18, issue.10, pp.2164-2173, 2008.

M. Rasschaert, A. Emerit, N. Fretellier, C. Factor, P. Robert et al., Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals, Investigative Radiology, vol.53, issue.6, pp.328-337, 2018.

A. European-medicines, EMA issues final opinion on linear gadolinium agents, Reactions Weekly, vol.1663, issue.1, pp.2-2, 2017.

D. Food and . Administration, Food and Drug Administration (FDA)

M. F. Tweedle, P. Wedeking, and K. Kumar, Biodistribution of Radiolabeled, Formulated Gadopentetate, Gadoteridol, Gadoterate, and Gadodiamide in Mice and Rats, Investigative Radiology, vol.30, issue.6, pp.372-380, 1995.

E. Di-gregorio, G. Ferrauto, C. Furlan, S. Lanzardo, R. Nuzzi et al., The Issue of Gadolinium Retained in Tissues, Investigative Radiology, vol.53, issue.3, pp.167-172, 2018.

A. Radbruch, H. Richter, S. Fingerhut, L. F. Martin, A. Xia et al., Gadolinium Deposition in the Brain in a Large Animal Model, Investigative Radiology, vol.54, issue.9, pp.531-536, 2019.

N. Cross, US FDA Guidances for Food Security, Handbook of Food Science, Technology, and Engineering - 4 Volume Set, 2005.

P. Robert, T. Frenzel, C. Factor, G. Jost, M. Rasschaert et al., Methodological Aspects for Preclinical Evaluation of Gadolinium Presence in Brain Tissue, Investigative Radiology, vol.53, issue.9, pp.499-517, 2018.

, Appendix D: Guidance for Industry Bioanalytical Method Validation by the Food and Drug Administration, Tobacco Smoke Exposure Biomarkers, pp.247-264, 2015.

R. D'agostino and E. S. Pearson, Tests for departure from normality. Empirical results for the distributions of b2 and ?b1, Biometrika, vol.60, issue.3, pp.613-622, 1973.

H. J. Motulsky and R. E. Brown, Detecting outliers when fitting data with nonlinear regression-a new method based on robust nonlinear regression and the false discovery rate, BMC Bioinformatics, vol.7, issue.1, p.123, 2006.

C. L. Kahakachchi and D. A. Moore, Identification and characterization of gadolinium(iii) complexes in biological tissue extracts, Metallomics, vol.2, issue.7, p.490, 2010.